Get alerts when RGEN reports next quarter
Set up alerts — freeThe stock rose 6.4% following better-than-expected revenue growth, margin expansion, and an improved full-year adjusted EPS outlook supported by strong demand across segments and accelerated strategic initiatives.
See RGEN alongside your other holdings
Add to your portfolio — freeTrack Repligen Corporation in your portfolio with real-time analytics, dividend tracking, and more.
View RGEN Analysis